Information Provided By: 
Fly News Breaks for October 9, 2018
TRHC
Oct 9, 2018 | 07:38 EDT
Citi analyst Stephanie Demko raised her price target for Tabula Rasa HealthCare to $100 and reiterates a Buy rating on the shares after meeting with management. The analyst updated her model for the Mediture and eClusive acquisitions and continues to believe in the company's "top-quartile growth." Management pointed to "healthy" double-digit revenue growth from the PACE program plus an "outsized opportunity" outside of PACE, Demko tells investors in a research note.
News For TRHC From the Last 2 Days
There are no results for your query TRHC
